Manageable medical device monitoring with real-world data

The FDA often requires some sort of post-market surveillance for medical devices to determine the long-term safety and effectiveness of products. In the past, FDA predominantly required passive surveillance that is reliant on self-reported adverse ev...

Extending value long after the clinical trial with real-world data

Subscribe to the blog

Contact us